Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sleep apnoea: causes, consequences and treatment.

S Nasser1, P J Rees

  • 1Department of Thoracic Medicine, Guys Hospital, London.

The British Journal of Clinical Practice
|January 1, 1992
PubMed
Summary

Sleep Apnoea Syndrome (SAS) affects 1-2% of the population, predominantly males. This sleep disorder causes disrupted sleep, daytime sleepiness, and serious long-term health risks, increasing mortality.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring infection risk factors and multi-drug-resistant organisms (MDROs) in burn intensive care units: a multi-centre case-control study.

The Journal of hospital infection·2025
Same author

EUFOREA meeting on defining disease states in allergic rhinitis: towards a unified language in AR.

Frontiers in allergy·2025
Same author

Influence of migrant background on patient preference and expectations in breast and gynecological malignancies (NOGGO-expression V study): results of a prospective multicentre study in 606 patients in Germany.

BMC cancer·2021
Same author

Retraction notice to " IP1867B suppresses the Insulin-like Growth Factor 1 Receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas" [Canc. Lett., 458 (2019) pages 29-38].

Cancer letters·2021
Same author

Corrigendum to "IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas." [Cancer Lett. 458C (2019) 29-38].

Cancer letters·2019
Same author

Insulin allergy with 'light-up' reaction.

Diabetic medicine : a journal of the British Diabetic Association·2019

Area of Science:

  • Sleep Medicine
  • Respiratory Medicine
  • Cardiology

Background:

  • Sleep disorders, particularly Sleep Apnoea Syndrome (SAS), have gained significant attention in the last 25 years.
  • SAS is a prevalent condition, affecting an estimated 1-2% of the population, with a higher incidence in males.
  • Prevalence increases with age, and while it occurs in children, adult cases typically present between 40-60 years old.

Purpose of the Study:

  • To highlight the medical and public awareness of Sleep Apnoea Syndrome.
  • To outline the clinical presentation and consequences of SAS.
  • To emphasize the association between SAS and increased mortality.

Main Methods:

  • The abstract summarizes existing knowledge and clinical observations regarding SAS.
  • It reviews the epidemiological data, including prevalence and demographic factors.
  • It discusses the physiological effects and long-term health implications of sleep-disordered breathing.

Main Results:

  • Numerous apnoeas and hypopnoeas lead to disordered sleep architecture and unrefreshing sleep, often accompanied by loud snoring.
  • Daytime symptoms include headaches, fatigue, and significant risks associated with sleepiness (e.g., driving, operating machinery).
  • Long-term consequences encompass cognitive decline, hypertension, heart disease, and increased mortality, particularly from cardiovascular events and arrhythmias.

Conclusions:

  • Sleep Apnoea Syndrome is a serious condition with widespread health implications.
  • Early recognition and management of SAS are crucial to mitigate risks.
  • SAS is linked to a higher incidence of cardiovascular disease, cerebrovascular disease, and arrhythmias, contributing to increased mortality.

Related Experiment Videos